High Frequency of HIV Mutations Associated with HLA-C Suggests Enhanced HLA-C–Restricted CTL Selective Pressure Associated with an AIDS-Protective Polymorphism

Delayed HIV-1 disease progression is associated with a single nucleotide polymorphism upstream of the HLA-C gene that correlates with differential expression of the HLA-C Ag. This polymorphism was recently shown to be a marker for a protective variant in the 3′UTR of HLA-C that disrupts a microRNA b...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of immunology (1950) Vol. 188; no. 9; pp. 4663 - 4670
Main Authors Blais, Marie-Eve, Zhang, Yonghong, Rostron, Tim, Griffin, Harry, Taylor, Stephen, Xu, Keyi, Yan, Huiping, Wu, Hao, James, Ian, John, Mina, Dong, Tao, Rowland-Jones, Sarah L
Format Journal Article
LanguageEnglish
Published England 01.05.2012
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Delayed HIV-1 disease progression is associated with a single nucleotide polymorphism upstream of the HLA-C gene that correlates with differential expression of the HLA-C Ag. This polymorphism was recently shown to be a marker for a protective variant in the 3′UTR of HLA-C that disrupts a microRNA binding site, resulting in enhanced HLA-C expression at the cell surface. Whether individuals with “high” HLA-C expression show a stronger HLA-C–restricted immune response exerting better viral control than that of their counterparts has not been established. We hypothesized that the magnitude of the HLA-C–restricted immune pressure on HIV would be greater in subjects with highly expressed HLA-C alleles. Using a cohort derived from a unique narrow source epidemic in China, we identified mutations in HIV proviral DNA exclusively associated with HLA-C, which were used as markers for the intensity of the immune pressure exerted on the virus. We found an increased frequency of mutations in individuals with highly expressed HLA-C alleles, which also correlated with IFN-γ production by HLA-C–restricted CD8+ T cells. These findings show that immune pressure on HIV is stronger in subjects with the protective genotype and highlight the potential role of HLA-C–restricted responses in HIV control. This is, to our knowledge, the first in vivo evidence supporting the protective role of HLA-C–restricted responses in nonwhites during HIV infection.
AbstractList Delayed HIV-1 disease progression is associated with a single nucleotide polymorphism upstream of the HLA-C gene that correlates with differential expression of the HLA-C Ag. This polymorphism was recently shown to be a marker for a protective variant in the 3'UTR of HLA-C that disrupts a microRNA binding site, resulting in enhanced HLA-C expression at the cell surface. Whether individuals with "high" HLA-C expression show a stronger HLA-C-restricted immune response exerting better viral control than that of their counterparts has not been established. We hypothesized that the magnitude of the HLA-C-restricted immune pressure on HIV would be greater in subjects with highly expressed HLA-C alleles. Using a cohort derived from a unique narrow source epidemic in China, we identified mutations in HIV proviral DNA exclusively associated with HLA-C, which were used as markers for the intensity of the immune pressure exerted on the virus. We found an increased frequency of mutations in individuals with highly expressed HLA-C alleles, which also correlated with IFN- gamma production by HLA-C-restricted CD8+ T cells. These findings show that immune pressure on HIV is stronger in subjects with the protective genotype and highlight the potential role of HLA-C-restricted responses in HIV control. This is, to our knowledge, the first in vivo evidence supporting the protective role of HLA-C-restricted responses in nonwhites during HIV infection.
Delayed HIV-1 disease progression is associated with a single nucleotide polymorphism upstream of the HLA-C gene that correlates with differential expression of the HLA-C Ag. This polymorphism was recently shown to be a marker for a protective variant in the 3'UTR of HLA-C that disrupts a microRNA binding site, resulting in enhanced HLA-C expression at the cell surface. Whether individuals with "high" HLA-C expression show a stronger HLA-C-restricted immune response exerting better viral control than that of their counterparts has not been established. We hypothesized that the magnitude of the HLA-C-restricted immune pressure on HIV would be greater in subjects with highly expressed HLA-C alleles. Using a cohort derived from a unique narrow source epidemic in China, we identified mutations in HIV proviral DNA exclusively associated with HLA-C, which were used as markers for the intensity of the immune pressure exerted on the virus. We found an increased frequency of mutations in individuals with highly expressed HLA-C alleles, which also correlated with IFN-γ production by HLA-C-restricted CD8(+) T cells. These findings show that immune pressure on HIV is stronger in subjects with the protective genotype and highlight the potential role of HLA-C-restricted responses in HIV control. This is, to our knowledge, the first in vivo evidence supporting the protective role of HLA-C-restricted responses in nonwhites during HIV infection.
Delayed HIV-1 disease progression is associated with a single nucleotide polymorphism upstream of the HLA-C gene that correlates with differential expression of the HLA-C antigen. This polymorphism was recently shown to be a marker for a protective variant in the 3′UTR of HLA-C that disrupts a microRNA binding site, resulting in enhanced HLA-C expression at the cell surface. Whether individuals with ‘high’ HLA-C expression show a stronger HLA-C-restricted immune response exerting better viral control than that of their counterparts has not been established. We hypothesised that the magnitude of the HLA-C-restricted immune pressure on HIV would be greater in subjects with highly expressed HLA-C alleles. Using a cohort derived from a unique narrow source epidemic in China, we identified mutations in HIV proviral DNA exclusively associated with HLA-C which were used as markers for the intensity of the immune pressure exerted on the virus. We found an increased frequency of mutations in individuals with highly expressed HLA-C alleles which also correlated with IFN-γ production by HLA-C-restricted CD8+ T-cells. These findings show that immune pressure on HIV is stronger in subjects with the protective genotype and highlights the potential role of HLA-C-restricted responses in HIV control. This is the first in vivo evidence supporting the protective role of HLA-C-restricted responses in non-Caucasians during HIV infection.
Delayed HIV-1 disease progression is associated with a single nucleotide polymorphism upstream of the HLA-C gene that correlates with differential expression of the HLA-C Ag. This polymorphism was recently shown to be a marker for a protective variant in the 3'UTR of HLA-C that disrupts a microRNA binding site, resulting in enhanced HLA-C expression at the cell surface. Whether individuals with "high" HLA-C expression show a stronger HLA-C-restricted immune response exerting better viral control than that of their counterparts has not been established. We hypothesized that the magnitude of the HLA-C-restricted immune pressure on HIV would be greater in subjects with highly expressed HLA-C alleles. Using a cohort derived from a unique narrow source epidemic in China, we identified mutations in HIV proviral DNA exclusively associated with HLA-C, which were used as markers for the intensity of the immune pressure exerted on the virus. We found an increased frequency of mutations in individuals with highly expressed HLA-C alleles, which also correlated with IFN-γ production by HLA-C-restricted CD8(+) T cells. These findings show that immune pressure on HIV is stronger in subjects with the protective genotype and highlight the potential role of HLA-C-restricted responses in HIV control. This is, to our knowledge, the first in vivo evidence supporting the protective role of HLA-C-restricted responses in nonwhites during HIV infection.Delayed HIV-1 disease progression is associated with a single nucleotide polymorphism upstream of the HLA-C gene that correlates with differential expression of the HLA-C Ag. This polymorphism was recently shown to be a marker for a protective variant in the 3'UTR of HLA-C that disrupts a microRNA binding site, resulting in enhanced HLA-C expression at the cell surface. Whether individuals with "high" HLA-C expression show a stronger HLA-C-restricted immune response exerting better viral control than that of their counterparts has not been established. We hypothesized that the magnitude of the HLA-C-restricted immune pressure on HIV would be greater in subjects with highly expressed HLA-C alleles. Using a cohort derived from a unique narrow source epidemic in China, we identified mutations in HIV proviral DNA exclusively associated with HLA-C, which were used as markers for the intensity of the immune pressure exerted on the virus. We found an increased frequency of mutations in individuals with highly expressed HLA-C alleles, which also correlated with IFN-γ production by HLA-C-restricted CD8(+) T cells. These findings show that immune pressure on HIV is stronger in subjects with the protective genotype and highlight the potential role of HLA-C-restricted responses in HIV control. This is, to our knowledge, the first in vivo evidence supporting the protective role of HLA-C-restricted responses in nonwhites during HIV infection.
Author Blais, Marie-Eve
Yan, Huiping
Rowland-Jones, Sarah L
Wu, Hao
John, Mina
Griffin, Harry
Dong, Tao
Taylor, Stephen
Xu, Keyi
Zhang, Yonghong
James, Ian
Rostron, Tim
AuthorAffiliation MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK OX3 9DS
Beijing Ditan Hospital, Capital Medical University, Beijing, PRC
Computational Biochemistry Research Group (CBRG), Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK OX3 9DS
Centre for Clinical Immunology and Biomedical Statistics, Institute for Immunology & Infectious Diseases, Murdoch University & Royal Perth Hospital, WA, 6155, Australia
Beijing You’An Hospital, Capital Medical University, Beijing, PRC
Nuffield Department of Medicine (NDM), John Radcliffe Hospital, Oxford, UK OX3 9DS
AuthorAffiliation_xml – name: Beijing Ditan Hospital, Capital Medical University, Beijing, PRC
– name: Computational Biochemistry Research Group (CBRG), Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK OX3 9DS
– name: Beijing You’An Hospital, Capital Medical University, Beijing, PRC
– name: Nuffield Department of Medicine (NDM), John Radcliffe Hospital, Oxford, UK OX3 9DS
– name: MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK OX3 9DS
– name: Centre for Clinical Immunology and Biomedical Statistics, Institute for Immunology & Infectious Diseases, Murdoch University & Royal Perth Hospital, WA, 6155, Australia
Author_xml – sequence: 1
  givenname: Marie-Eve
  surname: Blais
  fullname: Blais, Marie-Eve
– sequence: 2
  givenname: Yonghong
  surname: Zhang
  fullname: Zhang, Yonghong
– sequence: 3
  givenname: Tim
  surname: Rostron
  fullname: Rostron, Tim
– sequence: 4
  givenname: Harry
  surname: Griffin
  fullname: Griffin, Harry
– sequence: 5
  givenname: Stephen
  surname: Taylor
  fullname: Taylor, Stephen
– sequence: 6
  givenname: Keyi
  surname: Xu
  fullname: Xu, Keyi
– sequence: 7
  givenname: Huiping
  surname: Yan
  fullname: Yan, Huiping
– sequence: 8
  givenname: Hao
  surname: Wu
  fullname: Wu, Hao
– sequence: 9
  givenname: Ian
  surname: James
  fullname: James, Ian
– sequence: 10
  givenname: Mina
  surname: John
  fullname: John, Mina
– sequence: 11
  givenname: Tao
  surname: Dong
  fullname: Dong, Tao
– sequence: 12
  givenname: Sarah L
  surname: Rowland-Jones
  fullname: Rowland-Jones, Sarah L
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22474021$$D View this record in MEDLINE/PubMed
BookMark eNqNUs1uEzEYtFARTQt3TshHLls-e3ft3QtSFFoSKYiKFK6W4_VmXe3awfYW5cY78AS8Gk-CSxLEj5DwxdL3zYxHnjlDJ9ZZjdBTAhcFFPWLWzMMo3X9BSGQF5w-QBNSlpAxBuwETQAozQhn_BSdhXALAAxo8QidUlrwAiiZoK9zs-nwldcfR23VDrsWzxcf8JsxymicDXgaglNGRt3gTyZ2eL6cZjO8GjcbHWLAl7aTVqXlj_m3z1_epbE36h4_u1nile61iuZO42uvQxi9_ktRWjxdvFpl197FI9b1u8H5bWfC8Bg9bGUf9JPDfY7eX13ezObZ8u3rxWy6zFRB65jlVV7Kkteq1jUrOeV12QBXLXAoQOYKcsnXBNoc6pJp3rBqXTWMtI0smnTq_By93Otux_WgG6Vt9LIXW28G6XfCSSN-31jTiY27E3nOK1ZWSeD5QcC79JshisEEpfteWu3GIAiQIuWU3v8PKFQVrUpGE_TZr7Z--jlGmABsD1DeheB1K5TZh5dcmj5pifuuiGNXxKEriQh_EI_a_6R8B6rRxq4
CitedBy_id crossref_primary_10_1016_j_celrep_2016_10_075
crossref_primary_10_3389_fimmu_2020_601089
crossref_primary_10_1128_JVI_02600_13
crossref_primary_10_1073_pnas_1312237110
crossref_primary_10_1038_ni_3147
crossref_primary_10_1093_hmg_ddv158
crossref_primary_10_3389_fimmu_2017_00746
crossref_primary_10_1126_science_1232685
crossref_primary_10_3389_fimmu_2018_02735
crossref_primary_10_3389_fgene_2022_862642
crossref_primary_10_1016_j_jim_2015_01_005
crossref_primary_10_1097_01_aids_0000432536_85335_c8
crossref_primary_10_1371_journal_pone_0255834
crossref_primary_10_4049_jimmunol_1700697
crossref_primary_10_1371_journal_pone_0127867
crossref_primary_10_3390_jcm11071887
crossref_primary_10_1016_j_humimm_2014_04_003
crossref_primary_10_1126_science_1241266
crossref_primary_10_1146_annurev_med_052511_135400
crossref_primary_10_1038_srep42470
crossref_primary_10_7554_eLife_69198
crossref_primary_10_1016_j_chom_2016_04_005
crossref_primary_10_3389_fimmu_2017_01496
crossref_primary_10_4049_jimmunol_1601679
crossref_primary_10_1016_j_humimm_2018_10_002
crossref_primary_10_1128_JVI_01711_17
crossref_primary_10_1128_mBio_00782_20
crossref_primary_10_3389_fimmu_2018_01316
crossref_primary_10_3389_fimmu_2014_00547
crossref_primary_10_1097_QAD_0000000000000574
crossref_primary_10_1126_science_1241854
crossref_primary_10_1016_j_meegid_2021_105180
crossref_primary_10_3390_cells10113108
crossref_primary_10_1016_j_chom_2017_06_008
crossref_primary_10_1111_imr_12071
crossref_primary_10_1038_srep10879
crossref_primary_10_1111_tan_12882
crossref_primary_10_1111_tan_13971
Cites_doi 10.1038/ng.486
10.1126/science.1069660
10.1126/science.1195271
10.1084/jem.176.4.937
10.1371/journal.pone.0003636
10.1016/j.virol.2010.06.002
10.1182/blood-2006-06-030668
10.1038/ng.694
10.1371/journal.pgen.1000791
10.1038/nature03113
10.1089/aid.1995.11.1221
10.1002/eji.200939634
10.1038/nm992
10.1038/nature07746
10.1002/eji.201040841
10.1371/journal.pone.0023603
10.1128/JVI.00619-10
10.1038/nature09914
10.1126/science.1143767
10.1002/hep.23101
10.1038/344439a0
10.1084/jem.20090365
10.1182/blood-2010-06-291963
10.1371/journal.ppat.1001033
10.1111/j.1365-2567.2011.03422.x
10.4049/jimmunol.1100316
10.1038/ng.311
10.4049/jimmunol.1100691
10.1128/JVI.02276-10
10.1097/QAD.0b013e328325d414
10.1016/S1074-7613(00)80065-5
10.4049/jimmunol.181.10.6770
10.1084/jem.20032044
10.1111/j.1365-2567.2011.03474.x
ContentType Journal Article
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7T5
7U9
H94
5PM
DOI 10.4049/jimmunol.1103472
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Immunology Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AIDS and Cancer Research Abstracts
Immunology Abstracts
Virology and AIDS Abstracts
DatabaseTitleList AIDS and Cancer Research Abstracts
MEDLINE

MEDLINE - Academic
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1550-6606
EndPage 4670
ExternalDocumentID PMC3378658
22474021
10_4049_jimmunol_1103472
Genre Multicenter Study
Clinical Trial
Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GrantInformation_xml – fundername: Medical Research Council
  grantid: G0600520
– fundername: Medical Research Council
  grantid: G1001046
– fundername: Medical Research Council
  grantid: G0801751
– fundername: Medical Research Council :
  grantid: G0801751(88451) || MRC_
GroupedDBID ---
-~X
.55
0R~
18M
1KJ
2WC
34G
39C
3O-
53G
5GY
5RE
5VS
5WD
79B
85S
AARDX
AAYXX
ABCQX
ABDFA
ABEJV
ABGNP
ABJNI
ABOCM
ABPPZ
ABXVV
ACGFO
ACGFS
ACIWK
ACNCT
ACPRK
ADBBV
ADIPN
ADNWM
AENEX
AETEA
AFHIN
AFOSN
AFRAH
AGORE
AHMMS
AHWXS
AIZAD
ALMA_UNASSIGNED_HOLDINGS
ARBBW
BAWUL
BCRHZ
BTFSW
CITATION
D0L
DIK
DU5
E3Z
EBS
EJD
F5P
FRP
GX1
IH2
K-O
KQ8
L7B
OCZFY
OK1
OWPYF
P0W
P2P
PQQKQ
R.V
RHI
ROX
RZQ
SJN
TR2
TWZ
W8F
WH7
WOQ
X7M
XJT
XSW
XTH
YHG
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7T5
7U9
H94
5PM
ID FETCH-LOGICAL-c429t-3835a579c9e96572795d07cf07040a3c03a7b10f30956e7d68b8d61fda4dddd93
ISSN 0022-1767
1550-6606
IngestDate Thu Aug 21 18:01:20 EDT 2025
Fri Jul 11 04:17:39 EDT 2025
Fri Jul 11 11:38:49 EDT 2025
Mon Jul 21 05:18:11 EDT 2025
Thu Apr 24 22:58:45 EDT 2025
Tue Jul 01 05:12:56 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Language English
License https://academic.oup.com/pages/standard-publication-reuse-rights
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c429t-3835a579c9e96572795d07cf07040a3c03a7b10f30956e7d68b8d61fda4dddd93
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
TD and SRJ equally collaborated to this work.
OpenAccessLink https://www.jimmunol.org/content/jimmunol/188/9/4663.full.pdf
PMID 22474021
PQID 1008828562
PQPubID 23479
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3378658
proquest_miscellaneous_1014110095
proquest_miscellaneous_1008828562
pubmed_primary_22474021
crossref_citationtrail_10_4049_jimmunol_1103472
crossref_primary_10_4049_jimmunol_1103472
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-05-01
PublicationDateYYYYMMDD 2012-05-01
PublicationDate_xml – month: 05
  year: 2012
  text: 2012-05-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle The Journal of immunology (1950)
PublicationTitleAlternate J Immunol
PublicationYear 2012
References Kulkarni (2025032410071712000_r6) 2011; 472
Moore (2025032410071712000_r13) 2002; 296
Kaye (2025032410071712000_r28) 1995; 11
Stojakovic (2025032410071712000_r34) 2008; 181
Mkhwanazi (2025032410071712000_r10) 2010; 405
Dong (2025032410071712000_r12) 2011; 118
Buranapraditkun (2025032410071712000_r19) 2011; 6
Goonetilleke (2025032410071712000_r22) 2009; 206
Zemmour (2025032410071712000_r33) 1992; 176
Corrah (2025032410071712000_r26) 2011; 85
Honda (2025032410071712000_r20) 2011; 41
Almeida (2025032410071712000_r21) 2011; 187
Strange (2025032410071712000_r31) 2010; 42
Blais (2025032410071712000_r29) 2011; 133
Ahlenstiel (2025032410071712000_r25) 2008; 118
Specht (2025032410071712000_r18) 2010; 84
Pereyra (2025032410071712000_r3) 2010; 330
Rauch (2025032410071712000_r15) 2009; 50
Kawashima (2025032410071712000_r16) 2009; 458
Makadzange (2025032410071712000_r9) 2010; 40
Zhang (2025032410071712000_r24) 2011; 187
Shrestha (2025032410071712000_r11) 2009; 23
Adnan (2025032410071712000_r8) 2006; 108
Fellay (2025032410071712000_r1) 2009; 5
Fellay (2025032410071712000_r2) 2007; 317
Leslie (2025032410071712000_r23) 2004; 10
Kulpa (2025032410071712000_r35) 2011; 134
Nair (2025032410071712000_r30) 2009; 41
Thomas (2025032410071712000_r4) 2009; 41
Dong (2025032410071712000_r14) 2004; 200
Lie (2025032410071712000_r32) 1990; 344
Cohen (2025032410071712000_r7) 1999; 10
Kiepiela (2025032410071712000_r17) 2004; 432
Catano (2025032410071712000_r5) 2008; 3
Fellay (2025032410071712000_r27) 2010; 6
References_xml – volume: 41
  start-page: 1290
  year: 2009
  ident: 2025032410071712000_r4
  article-title: HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C
  publication-title: Nat. Genet.
  doi: 10.1038/ng.486
– volume: 296
  start-page: 1439
  year: 2002
  ident: 2025032410071712000_r13
  article-title: Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level
  publication-title: Science
  doi: 10.1126/science.1069660
– volume: 330
  start-page: 1551
  year: 2010
  ident: 2025032410071712000_r3
  article-title: The major genetic determinants of HIV-1 control affect HLA class I peptide presentation
  publication-title: Science
  doi: 10.1126/science.1195271
– volume: 176
  start-page: 937
  year: 1992
  ident: 2025032410071712000_r33
  article-title: Distinctive polymorphism at the HLA-C locus: implications for the expression of HLA-C
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.176.4.937
– volume: 3
  start-page: e3636
  year: 2008
  ident: 2025032410071712000_r5
  article-title: HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B*57 alleles
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0003636
– volume: 405
  start-page: 483
  year: 2010
  ident: 2025032410071712000_r10
  article-title: Immunodominant HIV-1-specific HLA-B- and HLA-C-restricted CD8+ T cells do not differ in polyfunctionality
  publication-title: Virology
  doi: 10.1016/j.virol.2010.06.002
– volume: 108
  start-page: 3414
  year: 2006
  ident: 2025032410071712000_r8
  article-title: Nef interference with HIV-1-specific CTL antiviral activity is epitope specific
  publication-title: Blood
  doi: 10.1182/blood-2006-06-030668
– volume: 42
  start-page: 985
  year: 2010
  ident: 2025032410071712000_r31
  article-title: A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1
  publication-title: Nat. Genet.
  doi: 10.1038/ng.694
– volume: 5
  start-page: e1000791
  year: 2009
  ident: 2025032410071712000_r1
  article-title: Common genetic variation and the control of HIV-1 in humans
  publication-title: PLoS Genet.
  doi: 10.1371/journal.pgen.1000791
– volume: 432
  start-page: 769
  year: 2004
  ident: 2025032410071712000_r17
  article-title: Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA
  publication-title: Nature
  doi: 10.1038/nature03113
– volume: 11
  start-page: 1221
  year: 1995
  ident: 2025032410071712000_r28
  article-title: The appearance of drug resistance-associated point mutations in HIV type 1 plasma RNA precedes their appearance in proviral DNA
  publication-title: AIDS Res. Hum. Retroviruses
  doi: 10.1089/aid.1995.11.1221
– volume: 40
  start-page: 1036
  year: 2010
  ident: 2025032410071712000_r9
  article-title: Characterization of an HLA-C-restricted CTL response in chronic HIV infection
  publication-title: Eur. J. Immunol.
  doi: 10.1002/eji.200939634
– volume: 10
  start-page: 282
  year: 2004
  ident: 2025032410071712000_r23
  article-title: HIV evolution: CTL escape mutation and reversion after transmission
  publication-title: Nat. Med.
  doi: 10.1038/nm992
– volume: 458
  start-page: 641
  year: 2009
  ident: 2025032410071712000_r16
  article-title: Adaptation of HIV-1 to human leukocyte antigen class I
  publication-title: Nature
  doi: 10.1038/nature07746
– volume: 41
  start-page: 97
  year: 2011
  ident: 2025032410071712000_r20
  article-title: Selection of escape mutant by HLA-C-restricted HIV-1 Pol-specific cytotoxic T lymphocytes carrying strong ability to suppress HIV-1 replication
  publication-title: Eur. J. Immunol.
  doi: 10.1002/eji.201040841
– volume: 6
  start-page: e23603
  year: 2011
  ident: 2025032410071712000_r19
  article-title: A novel immunodominant CD8+ T cell response restricted by a common HLA-C allele targets a conserved region of Gag HIV-1 clade CRF01_AE infected Thais
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0023603
– volume: 84
  start-page: 7300
  year: 2010
  ident: 2025032410071712000_r18
  article-title: Counteraction of HLA-C-mediated immune control of HIV-1 by Nef
  publication-title: J. Virol.
  doi: 10.1128/JVI.00619-10
– volume: 472
  start-page: 495
  year: 2011
  ident: 2025032410071712000_r6
  article-title: Differential microRNA regulation of HLA-C expression and its association with HIV control
  publication-title: Nature
  doi: 10.1038/nature09914
– volume: 317
  start-page: 944
  year: 2007
  ident: 2025032410071712000_r2
  article-title: A whole-genome association study of major determinants for host control of HIV-1
  publication-title: Science
  doi: 10.1126/science.1143767
– volume: 118
  start-page: 1017
  year: 2008
  ident: 2025032410071712000_r25
  article-title: Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses
  publication-title: J. Clin. Invest.
– volume: 50
  start-page: 1017
  year: 2009
  ident: 2025032410071712000_r15
  article-title: Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressure
  publication-title: Hepatology
  doi: 10.1002/hep.23101
– volume: 344
  start-page: 439
  year: 1990
  ident: 2025032410071712000_r32
  article-title: Peptide ligand-induced conformation and surface expression of the Ld class I MHC molecule
  publication-title: Nature
  doi: 10.1038/344439a0
– volume: 206
  start-page: 1253
  year: 2009
  ident: 2025032410071712000_r22
  article-title: The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20090365
– volume: 118
  start-page: 98
  year: 2011
  ident: 2025032410071712000_r12
  article-title: Extensive HLA-driven viral diversity following a narrow-source HIV-1 outbreak in rural China
  publication-title: Blood
  doi: 10.1182/blood-2010-06-291963
– volume: 6
  start-page: e1001033
  year: 2010
  ident: 2025032410071712000_r27
  article-title: Host genetics and HIV-1: the final phase?
  publication-title: PLoS Pathog.
  doi: 10.1371/journal.ppat.1001033
– volume: 133
  start-page: 1
  year: 2011
  ident: 2025032410071712000_r29
  article-title: HLA-C as a mediator of natural killer and T-cell activation: spectator or key player?
  publication-title: Immunology
  doi: 10.1111/j.1365-2567.2011.03422.x
– volume: 187
  start-page: 684
  year: 2011
  ident: 2025032410071712000_r24
  article-title: Multilayered defense in HLA-B51-associated HIV viral control
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1100316
– volume: 41
  start-page: 199
  year: 2009
  ident: 2025032410071712000_r30
  article-title: Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways
  publication-title: Nat. Genet.
  doi: 10.1038/ng.311
– volume: 187
  start-page: 2502
  year: 2011
  ident: 2025032410071712000_r21
  article-title: Translation of HLA-HIV associations to the cellular level: HIV adapts to inflate CD8 T cell responses against Nef and HLA-adapted variant epitopes
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1100691
– volume: 85
  start-page: 3367
  year: 2011
  ident: 2025032410071712000_r26
  article-title: Reappraisal of the relationship between the HIV-1-protective single-nucleotide polymorphism 35 kilobases upstream of the HLA-C gene and surface HLA-C expression
  publication-title: J. Virol.
  doi: 10.1128/JVI.02276-10
– volume: 23
  start-page: 673
  year: 2009
  ident: 2025032410071712000_r11
  article-title: Host genetics and HIV-1 viral load set-point in African-Americans
  publication-title: AIDS
  doi: 10.1097/QAD.0b013e328325d414
– volume: 10
  start-page: 661
  year: 1999
  ident: 2025032410071712000_r7
  article-title: The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells
  publication-title: Immunity
  doi: 10.1016/S1074-7613(00)80065-5
– volume: 181
  start-page: 6770
  year: 2008
  ident: 2025032410071712000_r34
  article-title: Adaptable TCR avidity thresholds for negative selection
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.181.10.6770
– volume: 200
  start-page: 1547
  year: 2004
  ident: 2025032410071712000_r14
  article-title: HIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptor
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20032044
– volume: 134
  start-page: 116
  year: 2011
  ident: 2025032410071712000_r35
  article-title: The emerging role of HLA-C in HIV-1 infection
  publication-title: Immunology
  doi: 10.1111/j.1365-2567.2011.03474.x
SSID ssj0006024
Score 2.2680106
Snippet Delayed HIV-1 disease progression is associated with a single nucleotide polymorphism upstream of the HLA-C gene that correlates with differential expression...
Delayed HIV-1 disease progression is associated with a single nucleotide polymorphism upstream of the HLA-C gene that correlates with differential expression...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 4663
SubjectTerms 3' Untranslated Regions - genetics
3' Untranslated Regions - immunology
Acquired Immunodeficiency Syndrome - epidemiology
Acquired Immunodeficiency Syndrome - genetics
Acquired Immunodeficiency Syndrome - immunology
Acquired Immunodeficiency Syndrome - metabolism
Alleles
Asian People
CD8-Positive T-Lymphocytes - immunology
CD8-Positive T-Lymphocytes - metabolism
China - epidemiology
DNA, Viral - genetics
DNA, Viral - immunology
DNA, Viral - metabolism
Female
Gene Expression Regulation - genetics
Gene Expression Regulation - immunology
HIV-1 - genetics
HIV-1 - immunology
HIV-1 - metabolism
HLA-C Antigens - biosynthesis
HLA-C Antigens - genetics
HLA-C Antigens - immunology
Human immunodeficiency virus 1
Humans
Interferon-gamma - genetics
Interferon-gamma - immunology
Interferon-gamma - metabolism
Male
Mutation
Polymorphism, Genetic
Proviruses - genetics
Proviruses - immunology
Proviruses - metabolism
Retrospective Studies
Title High Frequency of HIV Mutations Associated with HLA-C Suggests Enhanced HLA-C–Restricted CTL Selective Pressure Associated with an AIDS-Protective Polymorphism
URI https://www.ncbi.nlm.nih.gov/pubmed/22474021
https://www.proquest.com/docview/1008828562
https://www.proquest.com/docview/1014110095
https://pubmed.ncbi.nlm.nih.gov/PMC3378658
Volume 188
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfKEIgXBANG-ZKR4AGhsKR2EvuxbJ06aAeCVhpPUT6cdagkqB9I45_hlT-Tu9hO0xZNgz5Erevabe-X853v_DtCXrAwdHnmJY5UqXB47seODDLmyATZs3KmfFUlyJ4E_TF_d-qftlq_G1lLy0XyJv3513Ml_yNVaAO54inZf5BsPSg0wHOQL1xBwnC9kowxSQNMT50NXYXK--DNDZcLk99m_3ubYt4fdB1MxDnDoNL8da-Y6Ph_1e58UljDI8XeB6MBaJGpVobmCOFMbY0HuqF7fPjZ-ajJHqq-5fTiWwnCs9SEX1dwbBi_53gsRdM_vayCbG5jS-LtNNbMB0N05J3ejxp89fb2l7I4m5Rm1a3iRXPc0zfoWyUV4Y5U1dqPZybh2WxxYK6ITShsHDnwQl23Y6W2RQOfsqGEeWB0pjIvdWmSzcWCg3OEi4X5xXgggnFdR2idl_vkQ3Q0HgyiUe90dI1c74BDgrUyDo_f12t-4Ha45aXHL6oD4jjD_ub46wbQllezmZzbsHZGd8htIyna1Zi7S1qq2CU3dOHSi11yc2hSMu6RXwhCWoOQljkFENIahHQFGoqgoRXYqAUhtSCkmyCkAEJag5BaEG6NFxd0A4S0CcL7ZHzUGx30HVP1w0nBNlo4DHyC2A9lKpUMfDCvpZ-5YZrD2sTdmKUui8PEAzWCFJoqzAKRiCzw8izmGTwke0B2irJQDwnlgolMeqGXS8VdlgkB7jrnTIjM6yg3aJN9K4ooNZT4WJllGoFrjMKLrPAiI7w2eVV_4rumg7mk73Mr3Qh0Ngbi4kKVyznyhAtkjgwu7eNxpHOUfpvsaUTUM4LZHXIwztskXMNK3QE549ffKc4nFXc8Y6EAp-PRFeZ9TG6tbsYnZGcxW6qnYIEvkmcV-P8Am6zhHA
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=High+Frequency+of+HIV+Mutations+Associated+with+HLA-C+Suggests+Enhanced+HLA-C-Restricted+CTL+Selective+Pressure+Associated+with+an+AIDS-Protective+Polymorphism&rft.jtitle=The+Journal+of+immunology+%281950%29&rft.au=Blais%2C+Marie-Eve&rft.au=Zhang%2C+Yonghong&rft.au=Rostron%2C+Tim&rft.au=Griffin%2C+Harry&rft.date=2012-05-01&rft.issn=0022-1767&rft.volume=188&rft.issue=9&rft.spage=4663&rft.epage=4670&rft_id=info:doi/10.4049%2Fjimmunol.1103472&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1767&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1767&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1767&client=summon